Treatment of hidradenitis suppurativa with intense pulsed light: A prospective study

Plastic and Reconstructive Surgery

Volumn 128, Issue 2, 2011, Pages 459-465

  Highton, Lyndsey ^a   Chan, Woan Yi ^a   Khwaja, Nadeem ^a   Laitung, J K G ^a  

^a ROYAL PRESTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AXILLA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INGUINAL REGION; LOW LEVEL LASER THERAPY; MALE; METHODOLOGY; MIDDLE AGED; PATIENT SATISFACTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SUPPURATIVE HIDRADENITIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AXILLA; FEMALE; FOLLOW-UP STUDIES; GROIN; HIDRADENITIS SUPPURATIVA; HUMANS; LASER THERAPY, LOW-LEVEL; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80051484350     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e31821e6fb5     Document Type: Article

References (22)

1. Revuz JE, Canoui-Poitrine F, Wolkenstein P, et al. Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies. J Am Acad Dermatol. 2008;59: 596-601.
2. Von Der Werth JM, Williams HC, Raeburn JA. The clinical genetics of hidradenitis suppurativa revisited. Br J Dermatol. 2000;142:947-953. (Pubitemid 30304606)
3. Attanoos RL, Appleton MA, Douglas-Jones AG. The pathogenesis of hidradenitis suppurativa: A closer look at apocrine and apocrine glands. Br J Dermatol. 1995;133:254-258.
4. Lapins J, Jarstrand C, Emtestam L. Coagulase-negative staphylococci are the most common bacteria found in cultures from deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery. Br J Dermatol. 1999; 140:90-95. (Pubitemid 29074537)
5. Wolkenstein P, Loundou A, Barrau K, Auguier P, Revuz J; Quality of Life Group of the French Society of Dermatology. Quality of life impairment in hidradenitis suppurativa: A study of 61 cases. J Am Acad Dermatol. 2007;56:621-623. (Pubitemid 46400178)
6. Jemec GB, Wendelboe P. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol. 1998;39:971-974. (Pubitemid 28547731)
7. Mortimer PS, Dawber RP, Gales MA, Moore RA. A doubleblind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol. 1986; 115:263-268. (Pubitemid 16055913)
8. Boer J, van Germert MJ. Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa. J Am Acad Dermatol. 1999;40:73-76. (Pubitemid 29051027)
9. Buckley DA, Rogers S. Cyclosporin-responsive hidradenitis suppurativa. J R Soc Med. 1995;88:289P-290P.
10. Jemec GB. Methotrexate is of limited value in the treatment of hidradenitis suppurativa. Clin Exp Dermatol. 2002; 27:523-529.
11. Giamarellos-Bourboulis EJ, Pelekanou E, Antonopoulou A, et al. An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa. Br J Dermatol. 2008;158:567-572. (Pubitemid 351239170)
12. O'Reilly DJ, Pleat JM, Richards AM. Treatment of hidradenitis suppurativa with botulinum toxin A. Plast Reconstr Surg. 2005;116:1575-1576. (Pubitemid 41456560)
13. Harrison BJ, Mudge M, Hughes LE. Recurrence after surgical treatment of hidradenitis suppurativa. Br Med J (Clin Res Ed.) 1987;294:487-489. (Pubitemid 17020466)
14. Gold M, Bridges TM, Bradshaw VL, Boring M. ALA-PDT and blue light therapy for hidradenitis suppurativa. J Drugs Dermatol. 2004;3(Suppl):S32-S35.
15. Strauss RM, Pollock B, Stables GI, Goulden V, Cunliffe WJ. Photodynamic therapy using aminolaevulinic acid does not lead to clinical improvement in hidradenitis suppurativa. Br J Dermatol. 2005;152:803-804. (Pubitemid 40571321)
16. Lapins J, Sartorius K, Emtestam L. Scanner-assisted carbon dioxide laser surgery: A retrospective follow-up study of patients with hidradenitis suppurativa. J AmAcad Dermatol. 2002; 47:280-285.
17. Babilas P, Schreml S, Szeimies R, Landthaler M. Intense pulsed light (IPL): A review. Lasers Surg Med. 2010;42:93-104.
18. Gold MH, Bradshaw VL, Boring MM, Bridges TM, Biron JA, Carter LN. The use of a novel intense pulsed light and heat source and ALA-PDT in the treatment of moderate to severe inflammatory acne vulgaris. J Drugs Dermatol. 2004:3(Suppl): S15-S19.
19. Sartorius K, Lapins J, Emtestam L, Jemec GB. Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol. 2003; 149:211-213. (Pubitemid 36966545)
20. Campbell MJ. Statistics at Square Two. London: BMJ Books; 2001.
21. Huang J, Luo X, Lu J, et al. IPL irradiation rejuvenates skin collagen via the bidirectional regulation of MMP-1 and TGF 1 mediated by MAPKs in fibroblasts. Lasers Med Sci. 2011;26:381-387
22. Yaping X, Wang B, Lu J, et al. Effect and mechanism of intense pulsed laser on skin aging in rats. Zhong Nan Da Xue Bao Yi Xue Ban 2009;34:375-381.